Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Mustang Bio Inc

MBIO ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.59

▲ +0.68%

Market Cap $4.50M · Vol 794

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$4.50M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

56.25

Momentum

Beta

2.06

vs Market

52W High

$1.84

67.72% below

52W Low

$0.53

12.08% above

Volume

794

Avg 4.45K

P/B

0.75

Price-to-book

ROE

N/A

Return on equity

Free Float

91.98%

Public shares

Shariah Compliance8 STANDARDS

✗ Mustang Bio Inc (MBIO) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MBIO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.83%

-10.33%

-6.09%

-32.04%

YTD

-39.45%

-66.63%

-99.69%

-99.97%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-1,921,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-14.28% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	0.75
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	7.58M

Technical Indicators

50-Day SMA	$0.66
200-Day SMA	$0.88
RSI (14)	56.25
Beta	2.06
52-Week High	$1.84
52-Week Low	$0.53

Volume Today	794
Avg Daily Volume (30D)	4.45K
Relative Volume	0.18x
Volatility (10D)	40.64
Volatility (30D)	67.59
Free Float	91.98%

Analyst Consensus

N/A

Current Price $0.59

Mean Target N/A

52W Low$0.53 52W High$1.84

Current

Target

$0.53 $1.84

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00FXTN439

ISINUS62818Q3020

CountryUnited States of America

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs into potential cures for cancers and autoimmune diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR T) therapies. Its pipeline is focused in two core areas: CAR T therapies for autoimmune diseases and hematologic malignancies and CAR T therapies for solid tumors. It is developing a CAR T therapy for hematologic malignancies and autoimmune diseases in partnership with Fred Hutchinson Cancer Center targeting CD20 and for solid tumors in partnership with City of Hope National Medical Center targeting IL13Ra2. It has also partnered with Nationwide Children’s Hospital for a herpes simplex virus type 1 oncolytic virus to enhance the activity of MB-101 for the treatment of patients with high-grade malignant brain tumors.